Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage

Journal of Clinical Investigation

Volumn 124, Issue 8, 2014, Pages 3645-3655

  Soria, Federico N ^a   Pérez Samartín, Alberto ^a   Martin, Abraham ^b   Gona, Kiran Babu ^b   Llop, Jordi ^b   Szczupak, Boguslaw ^b   Chara, Juan Carlos ^a   Matute, Carlos ^a   Domercq, María ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CIC BIOMAGUNE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTINE GLUTAMATE ANTIPORTER; EXCITATORY AMINO ACID TRANSPORTER; GLUCOSE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXYGEN; UNCLASSIFIED DRUG; 4-CARBOXYPHENYLGLYCINE; AMINO ACID TRANSPORTER; BENZOIC ACID DERIVATIVE; GLYCINE; SLC7A11 PROTEIN, MOUSE; VESICULAR GLUTAMATE TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SLICE; CONTROLLED STUDY; EXTRACELLULAR SPACE; MOUSE; NERVE CELL LESION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL NECROSIS; NEUROIMAGING; NEUROTRANSMITTER RELEASE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; SYNAPSE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; C3H MOUSE; CELL DEATH; CHANNEL GATING; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SPRAGUE DAWLEY RAT;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; BENZOATES; BRAIN ISCHEMIA; CELL DEATH; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; GLYCINE; ION CHANNEL GATING; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 84905460022     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI71886     Document Type: Article

References (78)

1. Burke JF, Lisabeth LD, Brown DL, Reeves MJ, Morgenstern LB. Determining stroke's rank as a cause of death using multicause mortality data. Stroke. 2012;43(8):2207-2211.
2. Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79(4):1431-1568.
3. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391-397.
4. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev. 2001;81(3):1065-1096.
5. Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 2000;403(6767):316-321.
6. Hamann M, Rossi DJ, Mohr C, Andrade AL, Attwell D. The electrical response of cerebellar Purkinje neurons to simulated ischaemia. Brain. 2005;128(pt 10):2408-2420.
7. Tymianski M. Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat Neurosci. 2011;14(11):1369-1373.
8. Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci. 2010;11(10):682-696.
9. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002;5(5):405-414.
10. Zhang SJ, et al. A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptorinduced neuronal cell death and ischemic brain damage. J Neurosci. 2011;31(13):4978-4990.
11. Zhang SJ, et al. Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron. 2007;53(4):549-562.
12. Tu W, et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell. 2010;140(2):222-234.
13. Karpova A, et al. Encoding and transducing the synaptic or extrasynaptic origin of NMDA receptor signals to the nucleus. Cell. 2013;152(5):1119-1133.
14. Stanika RI, et al. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci U S A. 2009;106(24):9854-9859.
15. Papouin T, et al. Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell. 2012;150(3):633-646.
16. Wroge CM, Hogins J, Eisenman L, Mennerick S. Synaptic NMDA receptors mediate hypoxic excitotoxic death. J Neurosci. 2012;32(19):6732-6742.
17. Baker DA, Xi Z-X, Shen H, Swanson CJ, Kalivas PW. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci. 2002;22(20):9134-9141.
18. Baker DA, Shen H, Kalivas PW. Cystine/glutamate exchange serves as the source for extracellular glutamate: modifications by repeated cocaine administration. Amino Acids. 2002;23(1-3):161-162.
19. Massie A, et al. Dopaminergic neurons of system x (c)-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. FASEB J. 2011;25(4):1359-1369.
20. De Bundel D, et al. Loss of system xc-does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J Neurosci. 2011;31(15):5792-5803.
21. Bannai S, Kitamura E. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem. 1980;255(6):2372-2376.
22. Lo M, Wang Y-Z, Gout PW. The x (c) - cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol. 2008;215(3):593-602.
23. Conrad M, Sato H. The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids. 2012;42(1):231-246.
24. Gasol E, Jiménez-Vidal M, Chillarón J, Zorzano A, Palacín M. Membrane topology of system xc-light subunit reveals a re-entrant loop with substrate-restricted accessibility. J Biol Chem. 2004;279(30):31228-31236.
25. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol. 2000;62(6):649-671.
26. McBean GJ. Cerebral cystine uptake: a tale of two transporters. Trends Pharmacol Sci. 2002;23(7):299-302.
27. Sasaki H, et al. Electrophile response elementmediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem. 2002;277(47):44765-44771.
28. Mysona B, Dun Y, Duplantier J, Ganapathy V, Smith SB. Effects of hyperglycemia and oxidative stress on the glutamate transporters GLAST and system xc-in mouse retinal Müller glial cells. Cell Tissue Res. 2009;335(3):477-488.
29. Buckingham SC, et al. Glutamate release by primary brain tumors induces epileptic activity. Nat Med. 2011;17(10):1269-1274.
30. Albrecht P, et al. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc-as a neuroprotective drug target. CNS Neurol Disord Drug Targets. 2010;9(3):373-382.
31. Domercq M, et al. System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol. 2007;178(10):6549-6556.
32. Lewerenz J, Maher P, Methner A. Regulation of xCT expression and system x (c) (-) function in neuronal cells. Amino Acids. 2012;42(1):171-179.
33. Jabaudon D, Scanziani M, Gähwiler BH, Gerber U. Acute decrease in net glutamate uptake during energy deprivation. Proc Natl Acad Sci U S A. 2000;97(10):5610-5615.
34. Gao J, et al. Coupling between NMDA receptor and acid-sensing ion channel contributes to ischemic neuronal death. Neuron. 2005;48(4):635-646.
35. Domercq M, et al. P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia. 2010;58(6):730-740.
36. Arbeloa J, Pérez-Samartín A, Gottlieb M, Matute C. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia. Neurobiol Dis. 2012;45(3):954-961.
37. Thompson RJ, Zhou N, MacVicar BA. Ischemia opens neuronal gap junction hemichannels. Science. 2006;312(5775):924-927.
38. Gebhardt C, Körner R, Heinemann U. Delayed anoxic depolarizations in hippocampal neurons of mice lacking the excitatory amino acid carrier 1. J Cereb Blood Flow Metab. 2002;22(5):569-575.
39. Lossi L, Alasia S, Salio C, Merighi A. Cell death and proliferation in acute slices and organotypic cultures of mammalian CNS. Prog Neurobiol. 2009;88(4):221-245.
40. Fujimoto S, Katsuki H, Kume T, Kaneko S, Akaike A. Mechanisms of oxygen glucose deprivation-induced glutamate release from cerebrocortical slice cultures. Neurosci Res. 2004;50(2):179-187.
41. + - independent glutamatergic vesicle release through actin filament depolymerization in area CA1 of the hippocampus. J Physiol. 2010;588(pt 9):1499-1514.
42. Fleidervish IA, Gebhardt C, Astman N, Gutnick MJ, Heinemann U. Enhanced spontaneous transmitter release is the earliest consequence of neocortical hypoxia that can explain the disruption of normal circuit function. J Neurosci. 2001;21(13):4600-4608.
43. Baker DA, et al. Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine. Neuropsychopharmacology. 2008;33(7):1760-1772.
44. Patel SA, Warren BA, Rhoderick JF, Bridges RJ. Differentiation of substrate and non-substrate inhibitors of transport system xc-: an obligate exchanger of L-glutamate and L-cystine. Neuropharmacology. 2004;46(2):273-284.
45. Bridges RJ, Natale NR, Patel SA. System xc-cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol. 2012;165(1):20-34.
46. Müller M, Somjen GG. Na (+) dependence and the role of glutamate receptors and Na (+) channels in ion fluxes during hypoxia of rat hippocampal slices. J Neurophysiol. 2000;84(4):1869-1880.
47. Doherty AJ, Collingridge GL, Jane DE. Antagonist activity of alpha-substituted 4-carboxyphenylglycine analogues at group I metabotropic glutamate receptors expressed in CHO cells. Br J Pharmacol. 1999;126(1):205-210.
48. Melendez R, Vuthiganon J, Kalivas P. Regulation of extracellular glutamate in the prefrontal cortex: focus on the cystine glutamate exchanger and group I metabotropic glutamate receptors. J Pharmacol. 2005;314(1):139-147.
49. Chintala S, et al. Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells. Proc Natl Acad Sci U S A. 2005;102(31):10964-10969.
50. Warr O, Takahashi M, Attwell D. Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange. J Physiol. 1999;514(514):783-793.
51. Tovar KR, Westbrook GL. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci. 1999;19(10):4180-4188.
52. Petralia RS, et al. Organization of NMDA receptors at extrasynaptic locations. Neuroscience. 2010;167(1):68-87.
53. Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013;14(6):383-400.
54. Fischer G, et al. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J Pharmacol Exp Ther. 1997;283(3):1285-1292.
55. Bartlett TE, et al. Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology. 2007;52(1):60-70.
56. Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol. 1993;44(4):851-859.
57. Edman S, et al. TCN 201 selectively blocks Glu-N2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner. Neuropharmacology. 2012;63(3):441-449.
58. Okamoto S, et al. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med. 2009;15(12):1407-1413.
59. Xia P, Chen HV, Zhang D, Lipton SA. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci. 2010;30(33):11246-11250.
60. Frizelle PA, Chen PE, Wyllie D J A. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2, 3-dioxo-1, 2, 3, 4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVPAAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: implications for studies of synaptic transmission. Mol Pharmacol. 2006;70(3):1022-1032.
61. Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci. 2007;27(5):1129-1138.
62. Baek S, et al. Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl) -L-glutamate for imaging xC-transporter using positron emission tomography in patients with non-small cell lung or breast cancer. Clin Cancer Res. 2012;18(19):5427-5437.
63. Koglin N, et al. Specific PET imaging of xC-transporter activity using a 18F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism. Clin Cancer Res. 2011;17(18):6000-6011.
64. Rojas S, et al. Modest MRI signal intensity changes precede delayed cortical necrosis after transient focal ischemia in the rat. Stroke. 2006;37(6):1525-1532.
65. Groc L, et al. NMDA receptor surface mobility depends on NR2A-2B subunits. Proc Natl Acad Sci U S A. 2006;103(49):18769-18774.
66. Harris AZ, Pettit DL. Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices. J Physiol. 2007;584(pt 2):509-519.
67. Hamann M, Rossi DJ, Marie H, Attwell D. Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischaemia. Eur J Neurosci. 2002;15(2):308-314.
68. Savaskan NE, et al. Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med. 2008;14(6):629-632.
69. Pampliega O, et al. Increased expression of cystine/glutamate antiporter in multiple sclerosis. J Neuroinflammation. 2011;8(1):63.
70. Qin Z, et al. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog. 2010;6(1):e1000742.
71. Ogunrinu TA, Sontheimer H. Hypoxia increases the dependence of glioma cells on glutathione. J Biol Chem. 2010;285(48):37716-37724.
72. Farkas E, Pratt R, Sengpiel F, Obrenovitch TP. Direct, live imaging of cortical spreading depression and anoxic depolarisation using a fluorescent, voltage-sensitive dye. J Cereb Blood Flow Metab. 2008;28(2):251-262.
73. Plenz D, Kitai ST. Organotypic cortex-striatummesencephalon cultures: the nigrostriatal pathway. Neurosci Lett. 1996;209(3):177-180.
74. Cavaliere F, Dinkel K, Reymann K. The subventricular zone releases factors which can be protective in oxygen/glucose deprivation-induced cortical damage: an organotypic study. Exp Neurol. 2006;201(1):66-74.
75. Zimmer J, Kristensen BW, Jakobsen B, Noraberg J. Excitatory amino acid neurotoxicity and modulation of glutamate receptor expression in organotypic brain slice cultures. Amino Acids. 2000;19(1):7-21.
76. Graulich J, et al. Acute neuronal injury after hypoxia is influenced by the reoxygenation mode in juvenile hippocampal slice cultures. Brain Res Dev Brain Res. 2002;137(1):35-42.
77. Ruiz A, Matute C, Alberdi E. Endoplasmic reticulum Ca (2+) release through ryanodine and IP (3) receptors contributes to neuronal excitotoxicity. Cell Calcium. 2009;46(4):273-281.
78. Justicia C, Pérez-Asensio FJ, Burguete MC, Salom JB, Planas AM. Administration of transforming growth factor-α reduces infarct volume after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 2001;21(9):1097-1104.